TTP resources for you
The International Society on Thrombosis and Haemostasis (ISTH) TTP Guideline
The ISTH TTP Guidelines are the first evidence-based, international guidelines on the diagnosis, treatment, and management of TTP. The guidelines emphasize the importance of diagnosis through clinical assessment or risk assessment tools, such as the French or PLASMIC score. Clinical assessment can help predict the likelihood of severe ADAMTS13 deficiency in a patient with suspected TTP and guide treatment decisions.1
Inform your approach to thrombotic thrombocytopenic purpura (TTP) treatment by understanding key clinical considerations and therapeutic options.
TTP resources for your patients
UnderstandingTTP.com (patient website)
Support and community with others living with TTP
The following groups can provide support and help connect you and your patients with others in the TTP community.*
Note that the opinions expressed by the organizations above do not necessarily reflect the views of Sanofi. Sanofi does not maintain and is not responsible for the content of communications for the listed organizations or their websites. This is not intended to be a comprehensive list of aTTP disease support organizations. These listings do not constitute an endorsement by Sanofi of information provided by any other organizations.
*Sites and organizations are not affiliated with Sanofi.
ADAMTS13=a disintegrin and metalloproteinase with thrombospondin type 1 motif, 13.
Reference: 1. Zheng XL, Vesely SK, Cataland SR, et al. ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura. J Thromb Haemost. 2020;18(10):2486-2495. doi:10.1111/jth.15006